LCO No. 2978 1 of 1
General Assembly Proposed Bill No. 923
January Session, 2025
LCO No. 2978
Referred to Committee on FINANCE, REVENUE AND
BONDING
Introduced by:
SEN. SOMERS, 18th Dist.
AN ACT CONCERNING THE RESEARCH AND DEVELOPMENT TAX
CREDIT EXCHANGE RATE FOR BIOTECHNOLOGY COMPANIES.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
That section 12-217ee of the general statutes be amended to increase 1
the research and development tax credit exchange rate to one hundred 2
per cent for biotechnology companies. 3
Statement of Purpose:
To increase the research and development tax credit exchange rate
under section 12-217ee of the general statutes to one hundred per cent
for biotechnology companies.